repurposing semaglutide and liraglutide for alcohol use disorder GLP-1 Agonists Show Promise in Treating Substance Disorders Obesity-fighting drugs may reduce alcohol

GLP-1 act by reducing appetite and therefore all food intake, SGLT2 increase excretion of glucose from the kidney

Zheng Y, Li Z, Li S et al (2024) Separable nanocomposite hydrogel microneedles for intradermal and sustained delivery of antigens to enhance adaptive immune responses

All products listed have been properly registered and approved by the Food and Drug Administration Philippines for safe consumption

Saper stresses that given the severe joint destruction rheumatoid arthritis can cause, conventional therapy should always be the mainstay of treatment

Southwest Plastic Surgery staff typically starts with a loading dose and begins to titrate up monthly as tolerated

Sci Rep 2021;11:12407